China Development Bank:企業の戦略・SWOT・財務情報

◆英語タイトル:China Development Bank - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8862
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

China Development Bank – Strategy, SWOT and Corporate Finance Report
Summary

China Development Bank – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

China Development Bank (CDB), formerly China Development Bank Corporation, is a development financial institution that offers long-to-medium term financing services, which serve the country’s key long-term economic and social development strategies and projects. The bank’s offering include loans, intermediary business, treasury, financial services, foreign exchange services, funds and international products. CDB offer loans for international co-operation; industry transformation and upgrade; and livelihood and social well-being. It also offers special loans and funds for industrial and social development in Africa, Europe, and Caribbean. The bank operates through branch offices in China and Hong Kong; and via representative offices in Egypt, Venezuela, Russia, Laos, the UK, and Brazil. CDB is headquartered in Beijing, China.

Scope

- Detailed information on China Development Bank required for business and competitor intelligence needs
- A study of the major internal and external factors affecting China Development Bank in the form of a SWOT analysis
- An in-depth view of the business model of China Development Bank including a breakdown and examination of key business segments
- Intelligence on China Development Bank’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about China Development Bank, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of China Development Bank and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess China Development Bank as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on China Development Bank’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
China Development Bank: Company Overview 9
China Development Bank: Overview and Key Facts 9
China Development Bank: Overview 9
China Development Bank: Key Facts 9
China Development Bank: Key Employees 10
China Development Bank: Key Employee Biographies 11
China Development Bank: Major Products and Services 12
China Development Bank: Company History 13
China Development Bank: Management Statement 17
China Development Bank: Locations and Subsidiaries 20
China Development Bank: Key Competitors 23
China Development Bank: Company Analysis 24
China Development Bank: Business Description 24
China Development Bank: SWOT Analysis 26
China Development Bank: SWOT Overview 26
China Development Bank: Strengths 26
China Development Bank: Weaknesses 27
China Development Bank: Opportunities 27
China Development Bank: Threats 27
China Development Bank: Corporate Financial Deals Activity 29
China Development Bank: Financial Deals Overview 29
China Development Bank: Top Deals 2014 – 2018YTD* 31
China Development Bank: Mergers and Acquisitions 32
China Development Bank: Capital Raising 33
China Development Bank: Divestments 34
China Development Bank: Recent Developments 35
China Development Bank: News and Events Summary 35
China Development Bank: Business Expansion 38
China Development Bank: Contracts 39
China Development Bank: Financial Deals 40
China Development Bank: Financial Performance 40
China Development Bank: Regulatory and Legal Events 41
China Development Bank: Strategy and Operations 41
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: China Development Bank: Key Facts
Table 2: China Development Bank: Key Employees
Table 3: China Development Bank: Company History
Table 4: China Development Bank: Locations and Subsidiaries
Table 5: China Development Bank: Key Competitors
Table 6: China Development Bank: Deal Activity by Deal Type - Volume (TTM*)
Table 7: China Development Bank: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: China Development Bank: M&A Average Deal Size - Value (US$m)
Table 9: China Development Bank: Top Deals 2014 - 2018YTD*
Table 10: China Development Bank: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: China Development Bank: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: China Development Bank: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: China Development Bank: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: China Development Bank: News and Events Summary
Table 15: China Development Bank: Business Expansion
Table 16: China Development Bank: Contracts
Table 17: China Development Bank: Financial Deals
Table 18: China Development Bank: Financial Performance
Table 19: China Development Bank: Regulatory and Legal Events
Table 20: China Development Bank: Strategy and Operations

List of Figures
Figure 1: China Development Bank: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: China Development Bank: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: China Development Bank: M&A Average Deal Size - Value (US$m)
Figure 4: China Development Bank: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: China Development Bank: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: China Development Bank: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: China Development Bank: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[China Development Bank:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmacyclics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s drugs and drug candidates are synthetic small-molecules that target major biochemical pathways …
  • Corcept Therapeutics Inc (CORT):製薬・医療:M&Aディール及び事業提携情報
    Summary Corcept Therapeutics Inc (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic an …
  • BKW AG (BKW)-エネルギー分野:企業M&A・提携分析
    Summary BKW AG (BKW) is a provider of energy services. The company plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and biomas …
  • Taris Biomedical LLC:企業のM&A・事業提携・投資動向
    Taris Biomedical LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taris Biomedical LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Bial – Portela & Ca SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Bial - Portela & Ca SA (BIAL) is a pharmaceutical company that discovers, develops and provides drugs for neurosciences and cardiovascular therapeutic areas. The company offers products such as anti-inflammatories, anti-diabetics, cardiovascular, anti-asthmatics, antibiotics, antidepressants …
  • Youlchon Chemical Co Ltd:企業の戦略・SWOT・財務情報
    Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ManpowerGroup, Inc.:企業の戦略・SWOT・財務情報
    ManpowerGroup, Inc. - Strategy, SWOT and Corporate Finance Report Summary ManpowerGroup, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Quotient Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Quotient Sciences Ltd (Quotient Sciences), formerly Pharmaceutical Profiles Group Ltd is a drug development service provider. The company offers services such as formulation development, clinical trial manufacturing, clinical pharmacology, and commercial manufacturing services. Its formulati …
  • Sumi-Eagle Corp:企業の戦略的SWOT分析
    Sumi-Eagle Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • Arabian Shield Cooperative Insurance Company:企業の戦略・SWOT・財務情報
    Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arabian Shield Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Buck Institute for Research on Aging-製薬・医療分野:企業M&A・提携分析
    Summary Buck Institute for Research on Aging (Buck Institute) is a healthcare institute that conducts research and offers educational services. The institute concentrates on understanding the connection between aging and chronic disease. It works to understand how normal aging contributes to the dev …
  • Seven Generations Energy Ltd (VII):石油・ガス:M&Aディール及び事業提携情報
    Summary Seven Generations Energy Ltd (7G) is an independent oil and gas exploration and development company that acquires, develops and explores natural gas resource plays for the production of natural gas in Canada. The company holds interests in the Alberta Deep Basin located in the south of Grand …
  • Citrix Systems Inc (CTXS):企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Speedway Motorsports Inc (TRK):企業の財務・戦略的SWOT分析
    Summary Speedway Motorsports Inc (SMI) is a marketer, promoter and sponsor of motorsports entertainment. The company offers smaller-scale, modified racing cars and parts. It also produces and broadcasts syndicated motorsports programming to radio stations. SMI offers souvenir merchandising including …
  • I-O Data Device, Inc. (6916):企業の財務・戦略的SWOT分析
    I-O Data Device, Inc. (6916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Avraham Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Avraham Pharmaceuticals Ltd (Avraham Pharmaceuticals) is a pharmaceutical company that develops novel products for treatment and prevention of neurodegenerative disorders. The company offers a product, Ladostigil. It offers product in the therapeutic area of mild cognitive impairment. Avraha …
  • H2O Retailing Corp:企業の戦略・SWOT・財務分析
    H2O Retailing Corp - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Spectrum Health System:企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆